November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Carl Ola Landgren: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs
Apr 14, 2024, 12:56

Carl Ola Landgren: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs

Carl Ola Landgren, Professor of Medicine, Chief of Myeloma Division at University of Miami, shared a post on X:

“I started the EVIDENCE meta-analysis in 2009. After 15 years of work, I will present 4/12 at ODAC: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs?”

Procced to the video.
Source: Carl Ola Landgren/X